UPMD-2 (Q54991704)

From Wikidata

Jump to navigation Jump to search

cell line

UPMD2
Uveal Primary Melanoma with Disomy-3 2

Language	Label	Description	Also known as
English	UPMD-2	cell line	UPMD2 Uveal Primary Melanoma with Disomy-3 2

Statements

1 reference

Cellosaurus release 49

15 July 2024

cancer cell line

1 reference

Cellosaurus release 49

15 July 2024

described by source

Novel cell lines derived by long-term culture of primary uveal melanomas

1 reference

Cellosaurus release 49

15 July 2024

Genetic and molecular characterization of uveal melanoma cell lines

1 reference

Cellosaurus release 49

15 July 2024

Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity.

1 reference

Cellosaurus release 49

15 July 2024

established from medical condition

1 reference

Cellosaurus release 49

15 July 2024

derived from organism type

unknown value

2 references

Cellosaurus release 44

31 January 2023

Cellosaurus release 49

15 July 2024

Identifiers

1 reference

Cellosaurus release 49

15 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54991704&oldid=2258587080"